Skip to content

To see the effect of two medicines namely Kutajadi kwatha and kadaradi kwatha in the disease diabetes

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Kutajadi Kwatha and Kadaradi Kwatha In The management Of Madhumeha W.S.R. To Pre Diabetic And Diabetic State(Type 2)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041754
Enrollment
60
Registered
2022-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients  of  either  sex  aged  between  20  to  65  years. 2 If  yes  in  any two  of  the  four: A  Blood  sugar  â??fasting  >  100  and  B PP > 140 mg/dl and    Glycosylated  Haemoglobin  (HbA1c)  >  5.7%  and  C Subjects  having  classical  symptoms  of  diabetes  with  random glucose  levels  >=200mg/dl ( 3 Subjects  who  are  able  to  come  for  follow  up  on  fixed  visits  and  are  well  aware  about  the treatment  plan.(only  type  2  DM  patients) 4 Subjects  willing  to  participate  and  able  to  provide  written  informed  consent.

Exclusion criteria

Exclusion criteria: 1 Age below  20  and  above  65yrs. 2 Subject  on    any other  AYUSH  medication  for  glucose  control. 3 Subjects  suffering  from  the  complications  of  Diabetes  mellitus  viz.,  diabetic  neuropathy, diabetic  nephropathy,  diabetic  retinopathy  etc.  which  require  an  urgent  treatment. 4 Uncontrolled  Hypertensive  subjects  (BP  with  or  without  medication  >140/90  mmHg  after  5 mins  of  rest). 5 Subjects  with  any  unstable  Heart  disease  or  known  cases  of  MI,  unstable  angina  or  CHF. ï??  Subjects  with  current  or  past  diagnosis  of  malignancy  (any  malignancy  diagnosis  in  last  five years). 6 Subjects  who  have  a  recent  history  or  who  are  currently  known  to  abuse  of  alcohol  or  drugs. 7 Subjects  suffering  from  major  systemic  illness  necessitating  long  term  drug  treatment (Rheumatoid  arthritis,  Psycho-Neuro-Endocrinal  disorders,  TB,  AIDS etc). 8 Subjects  having  hypersensitivity  to  any  of  the  trial  drug. 9 Subjects  who  have  completed  participation  in  any  other  clinical  trial  during  the past  six  (06) months.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parameters 1.  Prabhoota  mootrata  â??  Polyurea 2.  Avila  mootrata  â??  Unclear  /  turbid  urine (excessive  urine) 3.  Kshudhaadhikya  -Polyphagia(  excessive  hunger) 4.  Pipasaadhikya  -Polydipsia  (excessive  thirst) 5.  Daurbalya/Shram-  Exhaustion  /  tiredness 6.  Suptaangta/Daha  -Polyneuritis  (numbness  /  tingling/  burning  of  soles) 7.  Pindikodveshtana  -  Cramps  while  walking/calf  muscle  pain 8.  Vibandh-  constipation 9.  Swedadikya 10.  Swapna  sukhaTimepoint: At baseline and after 12 weeksÂ

Secondary

MeasureTime frame
Assessment will be done clinically on basis of improvement in objective parameters like 1. Blood sugar fasting (in mg/dl) 2. Blood sugar post prandial(in mg/dl) 3. Glycosylated Haemoglobin (HbA1c in %)Timepoint: to be assessed at the beginning and at the end of the trial

Countries

India

Contacts

Public ContactDr SUJATA YADAV

Ayurvedic and Unani Tibbia College Hospital

sujatakcdelhi@gmail.com9354925030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026